MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0006367
Sridhara Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.8 Cr
▲ 37% YoY
Net profit · FY 2025
₹25.56 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹52.29 Lakh
EBITDA margin 3.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.69 Cr
Issued & subscribed
Open charges
₹9.13 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
14
Provident fund records
About Sridhara Laboratories Private Limited
Data last updated:
Sridhara Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC078321. Its GSTIN is 36AAQCS7592A1ZY (Telangana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.69 Cr. It is led by directors including Srinivas Polavarapu (Managing Director) and Ranga Reddy Tamma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.158 159 169 & 170 Sy No. 305 306/Part 308 Part And 312 S V C I E Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.8 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹25.56 Lakh (net margin 1.7%) and EBITDA of ₹52.29 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sridhara Laboratories Pvt. As per MCA filings, the company has open charges of ₹9.13 Cr on record.
Sridhara Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0006367). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sridharalabs.com.
Company details
CIN U24232TG2011PTC078321
Registration Number 078321
Incorporation Date 30 December 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0006367
CIN history
Sridhara Laboratories has one previous CIN (Corporate Identification Number): U24232AP2011PTC078321. The current CIN is U24232TG2011PTC078321, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC078321 | Current |
| U24232AP2011PTC078321 | Previous |
Key People
Srinivas Polavarapu Managing Director Ranga Reddy Tamma Director Narasimha Murthy Kattunga Director Recognitions & Rankings of Sridhara Laboratories
Contact details
Sridhara Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is sridharalabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.158 159 169 & 170 Sy No. 305 306/Part 308 Part And 312 S V C I E Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sridhara Laboratories Private Limited, buy the company report.
Comprehensive company report
Sridhara Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sridhara Laboratories operates one associated brand: Sridhara Laboratories Pvt. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical manufacturing, CRO services, and technology development for healthcare industry. | sridharalabs.com |
Business activity
The main business activity of Sridhara Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sridhara Laboratories Private Limited, buy the company report.
Financials of Sridhara Laboratories Private Limited
FY 2025 filings availableSridhara Laboratories Private Limited reported revenue of ₹14.8 Cr (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹14.8 Cr ▲ 37%
Net profit · FY 2025
₹25.56 Lakh margin 1.7%
EBITDA · FY 2025
₹52.29 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 4%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▼ 11%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 37% growth in the latest year. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sridhara Laboratories Private Limited, buy the company report.
Board of directors of Sridhara Laboratories Private Limited
Sridhara Laboratories has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranga Reddy Tamma | Director | 30 Dec 2011 | 14 Years 9 Months | Current |
| Srinivas Polavarapu | Managing Director | 30 Dec 2011 | 14 Years 9 Months | Current |
| Narasimha Murthy Kattunga | Director | 04 Mar 2015 | 11 Years 7 Months | Current |
| Hitesh Jain | Director | 04 Mar 2015 | 11 Years 7 Months | Current |
| Venkateswara Prasad Dagupati | Director | 04 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Sridhara Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kureasia Pharma Private Limited | ₹14.86 Cr (FY 2024) | 56.0% | New Delhi, Delhi, India | |||
| B D Pharmaceutical Works Private Limited | ₹14.82 Cr (FY 2024) | 11.0% | Kolkata, West Bengal, India | |||
| Vav Lipids Private Limited | ₹14.81 Cr (FY 2024) | -17.0% | Mumbai, Maharashtra, India | |||
| Sridhara Laboratories Private Limitedthis company | ₹14.8 Cr (FY 2025) | ₹25.56 Lakh | 1.7% | 37.0% | 14 | Hyderabad, Telangana, India |
| Crescent R&D Private Limited | ₹14.67 Cr (FY 2024) | -57.0% | Sriperumbudur, Tamil Nadu, India | |||
| Decro Pharma Private Limited | ₹14.66 Cr (FY 2025) | 96.0% | Indrad, Gujarat, India |
To see the full peer comparison of Sridhara Laboratories Private Limited, buy the company report.
Shareholding
The shareholding of Sridhara Laboratories Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sridhara Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.13 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101078565 | Axis Bank Limited | ₹1.1 Cr | Open | |
| 23 Dec 2021 | 100551434 | Axis Bank Limited | ₹53 Lakh | Open | |
| 12 Feb 2020 | 100332921 | Axis Bank Limited | ₹4.5 Cr | Open | |
| 06 Feb 2016 | 10621394 | Others | ₹1.25 Cr | Open | |
| 08 Sep 2015 | 10594530 | The Adarsh Co-Operative Urban Bank Ltd | ₹1.75 Cr | Open |
To see the full charge records of Sridhara Laboratories Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Sridhara Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sridhara Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sridhara Laboratories Private Limited has a workforce of 14 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
GST
Sridhara Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAQCS7592A1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sridhara Laboratories Private Limited, buy the company report.
Recent activity
Sridhara Laboratories Private Limited has 10 board changes on record since 2011: 5 appointments and 5 cessations. The latest: Hitesh Jain ceased to be Additional Director on 30 Sep 2015.
Charges
A charge with Axis Bank Limited of Rs. 4.50 Cr registered on 12 Feb 2020 with Charge ID 100332921 was modified on 11 Dec 2025.
AGM
Sridhara Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sridhara Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.10 Cr with Charge ID 101078565 was registered on 26 Mar 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.53 Cr with Charge ID 100551434 was registered on 23 Dec 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.50 Cr with Charge ID 100332921 was registered on 12 Feb 2020.
Charges
A charge with Others of Rs. 1.25 Cr registered on 06 Feb 2016 with Charge ID 10621394 was modified on 15 Mar 2018.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 10621394 was registered on 06 Feb 2016.
Ceased
Hitesh Jain ceased to be Additional Director.
Ceased
Narasimha Murthy Kattunga ceased to be Additional Director.
Ceased
Venkateswara Prasad Dagupati ceased to be Additional Director.
Charges
A charge with The Adarsh Co-Operative Urban Bank Ltd amounted to Rs. 1.75 Cr with Charge ID 10594530 was registered on 08 Sep 2015.
8 earlier events are in the company report.
Frequently asked questions
Sridhara Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2011 (15+ years old) and is registered under CIN U24232TG2011PTC078321.
Sridhara Laboratories has 5 current directors:
- Srinivas Polavarapu - Managing Director
- Ranga Reddy Tamma - Director
- Narasimha Murthy Kattunga - Director
- Hitesh Jain - Director
- Venkateswara Prasad Dagupati - Director
The latest financial statements of Sridhara Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sridhara Laboratories is 36AAQCS7592A1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Sridhara Laboratories is U24232TG2011PTC078321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sridhara Laboratories was incorporated on 30 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sridhara Laboratories by revenue are Kureasia Pharma Private Limited, B D Pharmaceutical Works Private Limited, Vav Lipids Private Limited, Crescent R&D Private Limited, Decro Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hitesh Jain ceased to be Additional Director on 30 Sep 2015. Narasimha Murthy Kattunga ceased to be Additional Director on 30 Sep 2015. Venkateswara Prasad Dagupati ceased to be Additional Director on 30 Sep 2015. Sridhara Laboratories has 10 board changes on record in total.
Yes, Sridhara Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0006367).
Sridhara Laboratories can be reached through the website sridharalabs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Sridhara Laboratories is at Plot No.158 159 169 & 170 Sy No. 305 306Part 308 Part And 312 S V C I E Jeedimetla, Hyderabad, Telangana, India – 500055.